Future Fields

Introducing Instar 1.0, our 6,000 square foot biofactory 🪰 Using fruit flies as sustainable bioreactors, Instar 1.0 will supply kilograms of recombinant proteins per year to meet increasing global demand. 🚀 Our co-founder and CEO gives a sneak peak of the impact and shares what this means for scientists developing the next generation of bioinnovations and medicine. 👇 Read the full story 👉 https://bit.ly/4fBPaKS

We’re thrilled to participate in the 2025 International Laboratory Freezer Challenge 🥶 for the third year in a row! 3️⃣ My Green Lab's Freezer Challenge has saved more than 76.5 million kWh of energy over seven years (equivalent to the electricity used by 10,500 homes in a year). We’re pleased to do our part by optimizing our lab’s cold storage and implementing other best practices. Good for your lab. Good for the planet 🌎❄️ Learn more (and join us!) 👉 https://bit.ly/43c9akm

Edmonton-based Future Fields has developed an innovative method that uses common fruit flies instead of microbes to produce recombinant proteins for the health and therapeutic industries, addressing the increasing demand for complex proteins in medicine while supporting advancements in drug and protein development. A $4.1 million investment will help Future Fields develop a specialized facility to scale production and meet critical quality standards. This project could potentially reduce greenhouse gas emissions in recombinant protein production by up to 75%, representing a significant step toward sustainable biomanufacturing. #IndustrialTransformationChallenge #ERAFunded

📢 We're thrilled to have received gracious financial support from the Government of Alberta and Emissions Reduction Alberta (ERA)! This funding helps to scale our sustainable biomanufacturing capacity of critical biomolecules for agriculture, biopharma, and beyond. 🚀 Powered by people and fly by design, we're proudly based in Alberta, Canada. Growing innovation right at home, we're working to improve life on Earth. 🌎 Read the news 👉 https://bit.ly/4hDgbig

This year, our BirA, PDGF-BB, and other lyophilized proteins will be shipped out in brand new boxes! ✨ Some fun facts about our box upgrade: 📦 Downsized and sturdy structure to keep your protein safe 🖨️ Printed with eco-friendly soy-based ink 🍃 Made with >50% recycled waste materials 🔁 Designed for you to keep and reuse P.S. Each side has a unique surprise 😉 Order a protein sample today: https://bit.ly/4jlgDDh

That's a wrap on #PepTalk2025! 🙌 We were thrilled to have attended Cambridge Healthtech Institute's annual conference on biotherapeutic discovery and development. It was rewarding and humbling to share insights with fellow protein scientists. 👨🔬👩🔬 Our CEO and co-founder Matt also delivered a presentation on our multicellular EntoEngine™, and how transgenic drosophila can resolve protein expression challenges and scale production. 🪰 Having special access to the #BioLogicSummit was also a treat—computational/AI approaches continue to make the future of protein exciting 👀

Hip-hip-hooray for #BirA! We’re thrilled to kick off 2025 by launching our first #enzyme. 🧡🎉 This is the start of many new milestones at Future Fields. Powered by people and fly by design, we look forward to serving scientists with more exciting developments of the EntoEngine! 🙌🪰 View BirA / request a sample / bulk pricing quote here: https://bit.ly/4akrxVv

📢 New protein alert! BirA is now available for your labs. 🧡 BirA is used to enzymatically biotinylate specific lysine residues on proteins with a biotin-acceptor peptide (BAP) tag. The biotinylated protein can then bind with high affinity to streptavidin or avidin for various downstream applications. Our BirA is high-purity and tag free. Request a sample/bulk pricing here: https://bit.ly/3Wcpopn #BirA #enzyme #productlaunch

Coming soon 👀🧡 Can you guess what our next recombinant protein will be? Hint… we think you’ll bond well to this one… #productlaunch #comingsoon

Happy new year! We're thrilled to be presenting at Cambridge Healthtech Institute's #PepTalk2025 in San Diego. Find us at the Protein Expression track on January 13, 2025 to learn more about how transgenic drosophila can solve expression challenges. 🪰